Increasing Patient Knowledge of the Signs of Opioid Overdose and Naloxone in a Suburban Treatment Program
NCT02120612 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2020-07-23
Summary
The purpose of this study is to determine the effect that an educational intervention has on patient knowledge of the signs of opioid overdose and appropriate use of naloxone in a suburban outpatient treatment program.
Conditions
- Opioid Dependence
- Opioid Use Disorder
Interventions
- OTHER
-
Naloxone Education Intervention
The Naloxone Education Intervention is a curriculum that has been adapted from New York State Department of Health's, "Opioid Overdose Prevention" program for non-medical responders.
Sponsors & Collaborators
-
Edward Hospital
lead OTHER
Principal Investigators
-
David C Lott, M.D. · Linden Oaks Hospital
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-04-30
- Primary Completion
- 2020-07-31
- Completion
- 2020-07-31
Countries
- United States
Study Locations
More Related Trials
-
Assessing Abuse Potential of Parenteral Buprenorphine/Naloxone in Non-Dependent Opioid Abusers
NCT00134875 ·Status: TERMINATED ·Phase: NA
-
Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-1 - 4
NCT00000329 ·Status: WITHDRAWN ·Phase: PHASE2
-
Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-3 - 6
NCT00000331 ·Status: WITHDRAWN ·Phase: PHASE2
-
Incentivizing Buprenorphine-Naloxone Initiation in Emergency Departments
NCT03821103 ·Status: COMPLETED ·Phase: NA
-
Effects of Buprenorphine and Naloxone in Opiate Addicts - 4
NCT00000355 ·Status: COMPLETED ·Phase: PHASE1
-
Increasing Naloxone Access for Persons Who Use Opioids
NCT04303000 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Buprenorphine/Naloxone Administered in Different Ways For Treating Opioid Dependence
NCT00134914 ·Status: COMPLETED ·Phase: NA
-
Naloxone Auto-injector as a Universal Precaution for Patients With Opioid Use Disorder
NCT02669901 ·Status: COMPLETED ·Phase: NA
-
Blockade Efficacy of Buprenorphine/Naloxone For Opioid Dependence
NCT00134888 ·Status: COMPLETED ·Phase: NA
-
User Acceptability of a Device-Based Opioid Overdose Intervention
NCT04530591 ·Status: COMPLETED
-
Nalox-Comm: Naloxone Communication Training for Pharmacists
NCT04677387 ·Status: COMPLETED ·Phase: NA
-
Overdose Risk Management and Naloxone
NCT03933345 ·Status: UNKNOWN
-
Abuse Potential of Buprenorphine and Naloxone in Non-Dependent Opioid Users
NCT00158236 ·Status: COMPLETED ·Phase: NA
-
Nasal Naloxone for Narcotic Overdose
NCT01912573 ·Status: UNKNOWN ·Phase: PHASE4
-
Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment I(2) - 2
NCT00000327 ·Status: WITHDRAWN ·Phase: PHASE2
-
Evaluation of Intranasal Naltrexone and Naloxone
NCT03851731 ·Status: COMPLETED ·Phase: PHASE1
-
Repeated-dose Brief Intervention to Reduce Overdose and Risk Behaviors Among Naloxone Recipients
NCT02093559 ·Status: COMPLETED ·Phase: NA
-
Optimizing Outcomes Using Suboxone for Opiate Dependence
NCT00591617 ·Status: COMPLETED ·Phase: NA
-
Low-dose Buprenorphine Initiation for Opioid Use Disorder
NCT05450718 ·Status: RECRUITING ·Phase: PHASE4
-
Long-Acting Injectable Naltrexone Treatment of Alcohol Dependence in Primary Care vs. in Specialized Chemical Dependence Treatment: A Pilot Trial
NCT00461890 ·Status: TERMINATED ·Phase: PHASE4
-
Piloting a Naloxone Intervention in Philadelphia
NCT03305497 ·Status: COMPLETED
-
Efficacy of Buprenorphine and XR-Naltrexone Combination for Relapse Prevention in Opioid Use Disorder
NCT05011266 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
A Usability Assessment of Naloxone Administration by Untrained Community Members
NCT04025671 ·Status: COMPLETED ·Phase: NA
-
Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment 1 - 1
NCT00000326 ·Status: WITHDRAWN ·Phase: PHASE2
-
Buprenorphine and Naloxone for the Treatment of Opiate Dependence - 1
NCT00015171 ·Status: COMPLETED ·Phase: PHASE3